After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...
Bronchodilators Don't Improve Smoking-Related Respiratory Symptoms in People Without COPD Sep. 5, 2022 — Researchers have found that dual bronchodilators -- long-lasting inhalers that relax the ...
Increasing Prevalence of Asthma and COPD: The rising incidence of asthma and chronic obstructive pulmonary disease (COPD) ...
The announcement that inhaled insulin will soon be available in India has understandably generated a lot of excitement and ...
Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.
Inc., an integrated clinical-stage biopharmaceutical company dedicated to developing inhaled medicines, today announced the ...
Hosted on MSN9d
Roth MKM Initiates Coverage of Verona Pharma plc - Depositary Receipt () (VRNA) with Buy RecommendationFintel reports that on January 10, 2025, Roth MKM initiated coverage of Verona Pharma plc - Depositary Receipt () ...
For patients with COPD, budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.
In a cohort of adults with chronic obstructive pulmonary disease (COPD), receiving fluticasone-umeclidinium-vilanterol was ...
Phillips Medisize parent company Molex has completed its acquisition of Vectura from a subsidiary of cigarette maker Philip ...
Phillips Medisize adds market-leading inhalation capabilities to its existing suite of drug delivery device design and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback